U.S. Stem Cell, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 9/08/2016
Contact Info
  • 13794 NW 4th Street
  • Suite 212
  • Sunrise, FL 33325

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001388319
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Incorporated In: FL, USA
Year of Inc. 1999
Employees Not Available
Company Officers/Contacts
Miguel Tomas President, CEO
Kristin Comella CSO
Jill Arlene Robbins Counsel
Company Directors
William P. Murphy Jr., M.D. Chairman
Sheldon Anderson
Mark P. Borman
Company Notes
  • Formerly=Bioheart, Inc. until 11-2015
Service Providers
Accounting/Auditing Firm
Fiondella, Milone & LaSaracina LLP
300 Winding Brook Dr
Glastonbury, CT, 06033
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available
USRM Security Details
Share Structure
Market Value1 $154,892 a/o Dec 02, 2016
Authorized Shares 2,000,000,000 a/o Aug 02, 2016
Outstanding Shares 59,573,684 a/o Nov 09, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Shareholders of Record 500 a/o Jul 26, 2016
Short Selling Data
Short Interest 2,272 (-84.84%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security